Detroit Receiving Hospital

About: Detroit Receiving Hospital is a healthcare organization based out in Detroit, Michigan, United States. It is known for research contribution in the topics: Vancomycin & Population. The organization has 877 authors who have published 850 publications receiving 37202 citations. The organization is also known as: Detroit General.

A Windows program to assist in preparing reports of emergency psychiatry nursing assessments

Abstract: The Emergency Psychiatry Nursing Assessment Report Framework (EP Nurse) is designed to guide the nurse through the interview-and-reporting process, and to produce a report of the nursing evaluation in emergency psychiatry in 5–10 min. Input includes identifying information, presenting complaints, substance-use history, medical history and vitals, psychiatric medications, treatment history, history of mental illness, last hospitalization, family history of mental illness, nursing diagnosis, and nursing intervention. EP Nurse is intended to be used by licensed nurses familiar with nursing assessment in emergency psychiatry. It is suitable for adult patients.

Use of Acid Suppression Agents following Acute, Nonvariceal, Upper Gastrointestinal Bleeding:

Abstract: Purpose: This study evaluated the utilization of acid suppression agents following upper gastrointestinal (GI) bleeding in the state of Michigan. Methods: A focus group was used to develop a one-page survey that consistedof questions pertaining to acid suppression agents following acute, upper GI bleeding. Survey consistency and validity were established through review by several experienced pharmacists practicing in either critical care or drug information. Surveys were mailed twice (at 30-day intervals) to the director of pharmacy at all hospitals (n = 267) in the state of Michigan. Results: Completed surveys were received from 76/267 (28.5%) institutions. Sixty-five percent of institutions stated that they had one preferred intravenous (IV) acid suppressive agent for acute GI bleeding, with 59% using a histamine-2 receptor antagonist (H 2 RA) and 41% using a proton pump inhibitor (PPI). When an IV PPI was prescribed, only 36% used a continuous infusion dosing regimen. For IV to oral step-down therapy, PPIs were chosen more often than H 2 RAs (81% vs 19%). Oral PPI therapy was usually initiated using a capsule/tablet (82%) as opposed to a PPI suspension (18%). Institutional guidelines for acid suppression were in place at only 23% of institutions, although 67% had restrictions for IV PPI use. Conclusion: Wide variation exists in the use of acid suppressive agents following upper GI bleeding in the state of Michigan.